Surgical management and outcome of synovial sarcoma in the spine

about

Surgical management and outcome of synovial sarcoma in the spine

Item

http://www.wikidata.org/entity/Q58701065

description

im August 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2018

@uk

name

Surgical management and outcome of synovial sarcoma in the spine

@en

Surgical management and outcome of synovial sarcoma in the spine

@nl

type

Item

label

Surgical management and outcome of synovial sarcoma in the spine

@en

Surgical management and outcome of synovial sarcoma in the spine

@nl

prefLabel

Surgical management and outcome of synovial sarcoma in the spine

@en

Surgical management and outcome of synovial sarcoma in the spine

@nl

P1476

Surgical management and outcome of synovial sarcoma in the spine

@en

P2093

Chenglong Zhao

http://www.w3.org/2001/XMLSchema#string

Jian Zhao

http://www.w3.org/2001/XMLSchema#string

Jianru Xiao

http://www.w3.org/2001/XMLSchema#string

Minglei Yang

http://www.w3.org/2001/XMLSchema#string

Nanzhe Zhong

http://www.w3.org/2001/XMLSchema#string

Shaohui He

http://www.w3.org/2001/XMLSchema#string

Wei Xu

http://www.w3.org/2001/XMLSchema#string

Xinghai Yang

http://www.w3.org/2001/XMLSchema#string

P2860

Synovial sarcoma of the spine: a case involving paraspinal muscle with extensive calcification and the surgical consideration in treatment

Synovial sarcoma in children and adolescents.

Surgical treatment of primary tumors of the sacrum.

Dual inhibition of the vascular endothelial growth factor pathway: a phase 1 trial evaluating bevacizumab and AZD2171 (cediranib) in patients with advanced solid tumors.

Metastatic synovial sarcoma with cervical spinal cord compression treated with posterior ventral resection: case report.

A phase 1 trial and pharmacokinetic study of cediranib, an orally bioavailable pan-vascular endothelial growth factor receptor inhibitor, in children and adolescents with refractory solid tumors.

Prognostic factors in advanced synovial sarcoma: an analysis of 104 patients treated at the Royal Marsden Hospital.

Chemotherapy is associated with improved survival in adult patients with primary extremity synovial sarcoma.

Neo/adjuvant chemotherapy does not improve outcome in resected primary synovial sarcoma: a study of the French Sarcoma Group.

Salvage rates and prognostic factors after relapse in children and adolescents with initially localised synovial sarcoma.

P2888

s12957-018-1471-x

P304

175

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12957-018-1471-X

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-08-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1106369961

http://www.w3.org/2001/XMLSchema#string

P698

30149806

http://www.w3.org/2001/XMLSchema#string

P932

6112132

http://www.w3.org/2001/XMLSchema#string